- 专利标题： MMP13 AS A THERAPEUTIC TARGET FOR ALLERGIC INFLAMMATORY DISEASES
-
申请号： PCT/US2022/072524申请日： 2022-05-24
-
公开(公告)号： WO2022251824A1公开(公告)日： 2022-12-01
- 发明人: PARK, Jin Mo , JIMENEZ-ANDRADE, Yanek
- 申请人： THE GENERAL HOSPITAL CORPORATION
- 申请人地址： 55 Fruit Street
- 专利权人： THE GENERAL HOSPITAL CORPORATION
- 当前专利权人： THE GENERAL HOSPITAL CORPORATION
- 当前专利权人地址： 55 Fruit Street
- 代理机构： GUZZO, Catherine et al.
- 优先权： US63/192,867 2021-05-25
- 主分类号： A61K31/18
- IPC分类号： A61K31/18 ; A61K31/505 ; A61K31/5377 ; A61P37/00
摘要：
Aspects of the present disclosure provide methods for treating allergic inflammatory diseases, such as allergic asthma and atopic dermatitis, using inhibitors of matrix metalloproteinase 13 (MMP13) such as small molecule inhibitors of MMP13.
